Genicular Artery Embolization Vs Observation for Symptomatic Knee Osteoarthritis

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

October 1, 2026

Study Completion Date

October 1, 2027

Conditions
Knee OsteoarthritisDegenerative Joint Disease of Knee
Interventions
DEVICE

Embozene MicroSpheres

Embozene is a medical device made by Boston Scientific approved in the United States for the treatment of hypervascular tumors and arteriovenous malformations. It consists of thousands of microscopic spheres that are injected into the artery in the knee going to the region of pain. One of the causes of pain in the setting of knee arthritis is increased blood flow going to the specific area of pain. The goal of this procedure is to decrease the blood flow (embolize) to the specific region of the knee that is causing your pain. This is done by infusing Embozene particles into the specific blood vessel (genicular artery) supplying the area of pain in the knee.

Trial Locations (1)

90404

RECRUITING

UCLA Santa Monica Hospital, Santa Monica

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Varian Medical Systems

INDUSTRY

lead

University of California, Los Angeles

OTHER

NCT04682652 - Genicular Artery Embolization Vs Observation for Symptomatic Knee Osteoarthritis | Biotech Hunter | Biotech Hunter